References

1.Wang J, et al. (2011) Further study of genetic association between the TNXB locus and schizophrenia. Psychiatric genetics 21(4):216.

2.Sullivan KE (1998) Complement deficiency and autoimmunity. Current opinion in pediatrics 10(6):600-606.

3.Gabrielsson BG, et al. (2003) High expression of complement components in omental adipose tissue in obese men. Obesity research 11(6):699-708.

4.Agrawal A, et al. (2011) A genome-wide association study of DSM-IV cannabis dependence. Addiction biology 16(3):514-518.

5.Healy BC, et al. (2010) HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology 75(7):634-640.

6.Carter CJ (2009) Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii. Schizophrenia bulletin 35(6):1163-1182.

7.International Schizophrenia C, et al. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460(7256):748-752.

8.Aberg KA, et al. (2013) A comprehensive family-based replication study of schizophrenia genes. JAMA psychiatry 70(6):573-581.

9.Clop A, et al. (2013) An in-depth characterization of the major psoriasis susceptibility locus identifies candidate susceptibility alleles within an HLA-C enhancer element. PloS one 8(8):e71690.

10.Takata A, et al. (2013) A population-specific uncommon variant in GRIN3A associated with schizophrenia. Biological psychiatry 73(6):532-539.

11.Wassink TH, Nopoulos P, Pietila J, Crowe RR, & Andreasen NC (2003) NOTCH4 and the frontal lobe in schizophrenia. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 118B(1):1-7.

12.Wei J & Hemmings GP (2000) The NOTCH4 locus is associated with susceptibility to schizophrenia. Nature genetics 25(4):376-377.

13.Luo X, et al. (2004) NOTCH4 gene haplotype is associated with schizophrenia in African Americans. Biological psychiatry 55(2):112-117.

14.Shibata N, et al. (2007) Genetic association between Notch4 polymorphisms and Alzheimer's disease in the Japanese population. The journals of gerontology. Series A, Biological sciences and medical sciences 62(4):350-351.

15.Swaminathan S, et al. (2012) Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. PloS one 7(12):e50640.

16.Nakatani N, et al. (2006) Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Human molecular genetics 15(12):1949-1962.

17.Hamza TH, et al. (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nature genetics 42(9):781-785.

18.Deng T, et al. (2013) Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell metabolism 17(3):411-422.

19.Quiroga I, et al. (2009) Association study of MICA and MICB in Alzheimer's disease. Tissue antigens 74(3):241-243.

20.Havik B, et al. (2011) The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. Biological psychiatry 70(1):35-42.

21.International Multiple Sclerosis Genetics C, et al. (2007) Risk alleles for multiple sclerosis identified by a genomewide study. The New England journal of medicine 357(9):851-862.

22.Grant A, Fathalli F, Rouleau G, Joober R, & Flores C (2012) Association between schizophrenia and genetic variation in DCC: a case-control study. Schizophrenia research 137(1-3):26-31.

23.Zhang C, Gao J, Zhang H, Sun L, & Peng G (2012) Robo2--slit and Dcc--netrin1 coordinate neuron axonal pathfinding within the embryonic axon tracts. The Journal of neuroscience : the official journal of the Society for Neuroscience 32(36):12589-12602.

24.Terracciano A, et al. (2011) Meta-analysis of genome-wide association studies identifies common variants in CTNNA2 associated with excitement-seeking. Translational psychiatry 1:e49.

25.Cummings AC, et al. (2012) Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene. Annals of human genetics 76(5):342-351.

26.Lesch KP, et al. (2008) Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. Journal of neural transmission 115(11):1573-1585.

27.Luchetti S, Bossers K, Frajese GV, & Swaab DF (2010) Neurosteroid biosynthetic pathway changes in substantia nigra and caudate nucleus in Parkinson's disease. Brain pathology 20(5):945-951.

28.Zou F, et al. (2013) Different functions of HIPK2 and CtBP2 in traumatic brain injury. Journal of molecular neuroscience : MN 49(2):395-408.

29.Zhao Z, et al. (2013) Association study of 167 candidate genes for schizophrenia selected by a multi-domain evidence-based prioritization algorithm and neurodevelopmental hypothesis. PloS one 8(7):e67776.

30.Xiang B, et al. (2012) [Genome-wide association study with memory measures as a quantitative trait locus for schizophrenia]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 29(3):255-259.

31.Fallin MD, et al. (2010) Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls. Neurogenetics 11(3):335-348.

32.Lalonde R & Strazielle C (2008) Discrimination learning in Rora(sg) and Grid2(ho) mutant mice. Neurobiology of learning and memory 90(2):472-474.

33.Sarachana T & Hu VW (2013) Genome-wide identification of transcriptional targets of RORA reveals direct regulation of multiple genes associated with autism spectrum disorder. Molecular autism 4(1):14.

34.Logue MW, et al. (2013) A genome-wide association study of post-traumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus. Molecular psychiatry 18(8):937-942.

35.Terracciano A, et al. (2010) Genome-wide association scan of trait depression. Biological psychiatry 68(9):811-817.

36.Le-Niculescu H, et al. (2009) Convergent functional genomics of genome-wide association data for bipolar disorder: comprehensive identification of candidate genes, pathways and mechanisms. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 150B(2):155-181.

37.Garriock HA, et al. (2010) A genomewide association study of citalopram response in major depressive disorder. Biological psychiatry 67(2):133-138.

38.Svensson AI (2010) The aromatase inhibitor 1,4,6-androstatriene-3,17-dione (ATD) reduces disinhibitory behavior in intact adult male rats treated with a high dose of testosterone. Behavioural brain research 206(2):216-222.

39.Edwards TL, et al. (2012) HTR1B, ADIPOR1, PPARGC1A, and CYP19A1 and obesity in a cohort of Caucasians and African Americans: an evaluation of gene-environment interactions and candidate genes. American journal of epidemiology 175(1):11-21.

40.Bayless DW, Darling JS, & Daniel JM (2013) Mechanisms by which neonatal testosterone exposure mediates sex differences in impulsivity in prepubertal rats. Hormones and behavior 64(5):764-769.

41.Morel N (2003) Neurotransmitter release: the dark side of the vacuolar-H+ATPase. Biology of the cell / under the auspices of the European Cell Biology Organization 95(7):453-457.

42.Medina AE (2011) Therapeutic utility of phosphodiesterase type I inhibitors in neurological conditions. Frontiers in neuroscience 5:21.

43.Morton DB, Clemens-Grisham R, Hazelett DJ, & Vermehren-Schmaedick A (2010) Infertility and male mating behavior deficits associated with Pde1c in Drosophila melanogaster. Genetics 186(1):159-165.

44.De Crescenzo V, et al. (2012) Type 1 ryanodine receptor knock-in mutation causing central core disease of skeletal muscle also displays a neuronal phenotype. Proceedings of the National Academy of Sciences of the United States of America 109(2):610-615.

45.Adasme T, et al. (2011) Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial memory formation. Proceedings of the National Academy of Sciences of the United States of America 108(7):3029-3034.

46.Dabertrand F, Nelson MT, & Brayden JE (2013) Ryanodine receptors, calcium signaling, and regulation of vascular tone in the cerebral parenchymal microcirculation. Microcirculation 20(4):307-316.

47.Matsuo N, et al. (2009) Comprehensive behavioral phenotyping of ryanodine receptor type 3 (RyR3) knockout mice: decreased social contact duration in two social interaction tests. Frontiers in behavioral neuroscience 3:3.

48.Galeotti N, Quattrone A, Vivoli E, Bartolini A, & Ghelardini C (2008) Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study. Neuroscience 153(3):814-822.

49.Kouzu Y, Moriya T, Takeshima H, Yoshioka T, & Shibata S (2000) Mutant mice lacking ryanodine receptor type 3 exhibit deficits of contextual fear conditioning and activation of calcium/calmodulin-dependent protein kinase II in the hippocampus. Brain research. Molecular brain research 76(1):142-150.

50.Stephens SH, et al. (2012) Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia. Psychiatric genetics 22(1):1-14.

51.Smith JD, Meehan MH, Crean J, & McCann A (2011) Alpha T-catenin (CTNNA3): a gene in the hand is worth two in the nest. Cellular and molecular life sciences : CMLS 68(15):2493-2498.

52.Berndt SI, et al. (2013) Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nature genetics 45(5):501-512.

53.Kim WS, Weickert CS, & Garner B (2008) Role of ATP-binding cassette transporters in brain lipid transport and neurological disease. Journal of neurochemistry 104(5):1145-1166.

54.Abuznait AH & Kaddoumi A (2012) Role of ABC transporters in the pathogenesis of Alzheimer's disease. ACS chemical neuroscience 3(11):820-831.

55.Tournier N, et al. (2010) Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum 13(7):905-915.

56.Wilker S, Elbert T, & Kolassa IT (2013) The downside of strong emotional memories: How human memory-related genes influence the risk for posttraumatic stress disorder - A selective review. Neurobiology of learning and memory.

57.Carroll LS, et al. (2010) Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha. Molecular psychiatry 15(11):1101-1111.

58.Rodd ZA, et al. (2008) Differential gene expression in the nucleus accumbens with ethanol self-administration in inbred alcohol-preferring rats. Pharmacology, biochemistry, and behavior 89(4):481-498.

59.Melen E, et al. (2010) Analyses of shared genetic factors between asthma and obesity in children. The Journal of allergy and clinical immunology 126(3):631-637 e631-638.

60.Girardin F (2006) Membrane transporter proteins: a challenge for CNS drug development. Dialogues in clinical neuroscience 8(3):311-321.

61.Tropeano M, et al. (2013) Male-biased autosomal effect of 16p13.11 copy number variation in neurodevelopmental disorders. PloS one 8(4):e61365.

62.Wang KS, Liu X, Zhang Q, Aragam N, & Pan Y (2011) Genome-wide association analysis of age at onset in schizophrenia in a European-American sample. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 156B(6):671-680.

63.Quezada-Calvillo R, et al. (2007) Luminal substrate "brake" on mucosal maltase-glucoamylase activity regulates total rate of starch digestion to glucose. Journal of pediatric gastroenterology and nutrition 45(1):32-43.

64.Williams S, Bateman A, & O'Kelly I (2013) Altered expression of two-pore domain potassium (K2P) channels in cancer. PloS one 8(10):e74589.

65.Bittner S, et al. (2010) Upregulation of K2P5.1 potassium channels in multiple sclerosis. Annals of neurology 68(1):58-69.

66.Folsom TD & Fatemi SH (2013) The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology 68:122-135.

67.Iafrati J, Orejarena MJ, Lassalle O, Bouamrane L, & Chavis P (2013) Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway. Molecular psychiatry.

68.Laviola G, Ognibene E, Romano E, Adriani W, & Keller F (2009) Gene-environment interaction during early development in the heterozygous reeler mouse: clues for modelling of major neurobehavioral syndromes. Neuroscience and biobehavioral reviews 33(4):560-572.

69.Brust PF, et al. (1993) Human neuronal voltage-dependent calcium channels: studies on subunit structure and role in channel assembly. Neuropharmacology 32(11):1089-1102.

70.Malki K, et al. (2012) Antidepressant-dependent mRNA changes in mouse associated with hippocampal neurogenesis in a mouse model of depression. Pharmacogenetics and genomics 22(11):765-776.

71.Marballi KK, et al. (2014) Global signaling effects of a schizophrenia-associated missense mutation in neuregulin 1: an exploratory study using whole genome and novel kinome approaches. Journal of neural transmission.

72.Wong ML, Dong C, Maestre-Mesa J, & Licinio J (2008) Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Molecular psychiatry 13(8):800-812.

73.Wefers B, et al. (2012) MAPK signaling determines anxiety in the juvenile mouse brain but depression-like behavior in adults. PloS one 7(4):e35035.

74.Zhang Q, et al. (2013) Histone modification mapping in human brain reveals aberrant expression of histone H3 lysine 79 dimethylation in neural tube defects. Neurobiology of disease 54:404-413.

75.Kahler AK, et al. (2008) Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 147B(7):1089-1100.

76.Nakayama Y, et al. (2012) A putative polypeptide N-acetylgalactosaminyltransferase/Williams-Beuren syndrome chromosome region 17 (WBSCR17) regulates lamellipodium formation and macropinocytosis. The Journal of biological chemistry 287(38):32222-32235.

77.Merla G, Ucla C, Guipponi M, & Reymond A (2002) Identification of additional transcripts in the Williams-Beuren syndrome critical region. Human genetics 110(5):429-438.

78.Okamoto N, et al. (2013) Williams-Beuren syndrome with brain malformation and hypertrophic cardiomyopathy. Brain & development.